1. 1. Quitterer, U., &AbdAlla, S. (2020). Improvements of symptoms of Alzheimers disease by inhibition of the angiotensin system. Pharmacological research, 154, 104230.
   2. Rabbito, A., Dulewicz, M., KulczyÅ„ska-Przybik, A., &Mroczko, B. (2020). Biochemical markers in Alzheimer’s disease. International journal of molecular sciences, 21(6), 1989.
   3. Liu, L., Zhao, S., Chen, H., & Wang, A. (2020). A new machine learning method for identifying Alzheimer's disease. Simulation Modelling Practice and Theory, 99, 102023.
   4. O’Bryant, S. E., Xiao, G., Barber, R., Reisch, J., Doody, R., Fairchild, T., ...& Texas Alzheimer's Research Consortium. (2010). A serum protein–based algorithm for the detection of Alzheimer disease. Archives of neurology, 67(9), 1077-1081.
   5. Jiang, Y., Zhou, X., Ip, F. C., Chan, P., Chen, Y., Lai, N. C., ...&Ip, N. Y. (2021). Large‐scale plasma proteomic profiling identifies a high‐ performance biomarker panel for Alzheimer's disease screening and staging. Alzheimer's & Dementia.
   6. O’Bryant, S. E., Xiao, G., Barber, R., Reisch, J., Hall, J., Cullum, C. M., ...& Diaz-Arrastia, R. (2011). A blood-based algorithm for the detection of Alzheimer’s disease. Dementia and geriatric cognitive disorders, 32(1), 55-62.
   7. O'Bryant, S. E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., Edwards, M., ...& Alzheimer's Disease Neuroimaging Initiative. (2011). A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PloS one, 6(12), e28092.
   8. Lee, J. C., Kim, S. J., Hong, S., & Kim, Y. (2019). Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers. Experimental & molecular medicine, 51(5), 1-10.
   9. Zetterberg, H., & Burnham, S. C. (2019). Blood-based molecular biomarkers for Alzheimer’s disease. Molecular brain, 12(1), 1-7.
   10. Ashton, N. J., Nevado-Holgado, A. J., Barber, I. S., Lynham, S., Gupta, V., Chatterjee, P., ...&Hye, A. (2019). A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease. Science advances, 5(2), eaau7220.
   11.  Hye, A., Lynham, S., Thambisetty, M., Causevic, M., Campbell, J., Byers, H. L., ...&Lovestone, S. (2006). Proteome-based plasma biomarkers for Alzheimer's disease. Brain, 129(11), 3042-3050.